---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-23-069219"
form_type: "8-K"
ticker: "IKT"
cik: "0001750149"
company_name: "Inhibikase Therapeutics, Inc."
filed_at: "2023-03-13T23:59:59+00:00"
generated_at: "2026-06-18T04:38:09.585949+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Inhibikase Therapeutics discloses no exposure to Silicon Valley Bank

## Summary
- Company holds no cash deposits or lines of credit with SVB.
- No business relationship with SVB exists.
- Filing aims to reassure investors amid SVB collapse.

## SEC filing metadata
- accession: 0001193125-23-069219
- form_type: 8-K
- ticker: IKT
- cik: 0001750149
- company_name: Inhibikase Therapeutics, Inc.
- filed_at: 2023-03-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1750149/000119312523069219/0001193125-23-069219-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1750149/000119312523069219/d475007d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-23-069219
- JSON: https://secwatch.observer/filing/0001193125-23-069219.json
- Plain text: https://secwatch.observer/filing/0001193125-23-069219.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.